These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 9618413)
21. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells. Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703 [TBL] [Abstract][Full Text] [Related]
22. In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model. Cummins CL; Salphati L; Reid MJ; Benet LZ J Pharmacol Exp Ther; 2003 Apr; 305(1):306-14. PubMed ID: 12649383 [TBL] [Abstract][Full Text] [Related]
23. Prediction of midazolam-CYP3A inhibitors interaction in the human liver from in vivo/in vitro absorption, distribution, and metabolism data. Yamano K; Yamamoto K; Katashima M; Kotaki H; Takedomi S; Matsuo H; Ohtani H; Sawada Y; Iga T Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):443-52. PubMed ID: 11259329 [TBL] [Abstract][Full Text] [Related]
24. The roles of CYP3A and CYP2B isoforms in hepatic bioactivation and detoxification of the pyrrolizidine alkaloid senecionine in sheep and hamsters. Huan JY; Miranda CL; Buhler DR; Cheeke PR Toxicol Appl Pharmacol; 1998 Aug; 151(2):229-35. PubMed ID: 9707499 [TBL] [Abstract][Full Text] [Related]
25. Cytochrome P450-mediated metabolism in the human gut wall. Thelen K; Dressman JB J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992 [TBL] [Abstract][Full Text] [Related]
26. Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine. Martignoni M; Groothuis G; de Kanter R Drug Metab Dispos; 2006 Jun; 34(6):1047-54. PubMed ID: 16565172 [TBL] [Abstract][Full Text] [Related]
27. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis. Kharasch ED; Walker A; Hoffer C; Sheffels P Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460 [TBL] [Abstract][Full Text] [Related]
28. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction. Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617 [TBL] [Abstract][Full Text] [Related]
29. The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: potential for drug-drug interaction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy. Dehal SS; Brodie AM; Kupfer D Drug Metab Dispos; 1999 Mar; 27(3):389-94. PubMed ID: 10064571 [TBL] [Abstract][Full Text] [Related]
30. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats. Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A J Pharm Pharmacol; 2004 Oct; 56(10):1259-66. PubMed ID: 15482640 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone. Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804 [TBL] [Abstract][Full Text] [Related]
32. Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats. Xu Y; Iwanaga K; Zhou C; Cheesman MJ; Farin F; Thummel KE Biochem Pharmacol; 2006 Jul; 72(3):385-92. PubMed ID: 16769037 [TBL] [Abstract][Full Text] [Related]
33. Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A. Chiba M; Hensleigh M; Lin JH Biochem Pharmacol; 1997 Apr; 53(8):1187-95. PubMed ID: 9175724 [TBL] [Abstract][Full Text] [Related]
34. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds. Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998 [TBL] [Abstract][Full Text] [Related]
36. Hepatic metabolism of ergot alkaloids in beef cattle by cytochrome P450. Moubarak AS; Rosenkrans CF Biochem Biophys Res Commun; 2000 Aug; 274(3):746-9. PubMed ID: 10924348 [TBL] [Abstract][Full Text] [Related]
37. Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Sattler M; Guengerich FP; Yun CH; Christians U; Sewing KF Drug Metab Dispos; 1992; 20(5):753-61. PubMed ID: 1385058 [TBL] [Abstract][Full Text] [Related]
38. Metabolism of tacrolimus (FK 506) in rat liver microsomes. Effect of rifampin and dexamethasone. Prasad ; Tata NV; Subbotina N; Burckart G; Swaminathan A; Gusev AI; Hercules DM; Venkataramanan R Res Commun Mol Pathol Pharmacol; 1997 Apr; 96(1):107-10. PubMed ID: 9178371 [TBL] [Abstract][Full Text] [Related]
39. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat. Witherow LE; Houston JB J Pharmacol Exp Ther; 1999 Jul; 290(1):58-65. PubMed ID: 10381760 [TBL] [Abstract][Full Text] [Related]
40. Isolation from pig liver microsomes, identification by electrospray tandem mass spectrometry and in vitro immunosuppressive activity of a rapamycin tris-epoxide metabolite. Lhoƫst G; Zey T; Verbeeck RK; Wallemacq P; Maton N; De Houx JP; Latinne D J Mass Spectrom; 1999 Jan; 34(1):28-32. PubMed ID: 10028689 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]